K · As filed with the SEC
Kellanova cash flow statement, by quarter
The statement as Kellanova presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) · USD millions
| USD millions | Q3 2025† 3 months ended Sep 27, 2025 | Q2 2025† 3 months ended Jun 28, 2025 | Q1 2025 3 months ended Mar 29, 2025 | Q4 2024† 3 months ended Dec 28, 2024 |
|---|---|---|---|---|
| Operating activities | ||||
| Net income | 314† | 303† | 308 | 368† |
| Adjustments to reconcile net income to operating cash flows: | ||||
| Depreciation and amortization | 94† | 91† | 92 | 94† |
| Impairment of property | 0† | 0† | 0 | 0† |
| Postretirement benefit plan expense (benefit) | (5)† | (6)† | (6) | — |
| Deferred income taxes | 14† | 19† | 68 | 37† |
| Stock compensation | (5)† | 14† | 22 | — |
| Loss on Russia divestiture | — | — | — | 0† |
| Other | (26)† | 6† | (23) | (83)† |
| Postretirement benefit plan distributions | 0† | 0† | 0 | 0† |
| Postretirement benefit plan contributions | (12)† | (133)† | (12) | 0† |
| Changes in operating assets and liabilities, net of acquisitions and divestitures: | ||||
| Trade receivables | (27)† | (90)† | 16 | 87† |
| Inventories | 57† | 4† | (46) | 18† |
| Accounts payable | (70)† | 26† | (106) | (106)† |
| All other current assets and liabilities | 169† | (65)† | (197) | 8† |
| Net cash provided by (used in) operating activities | 503† | 169† | 116 | 467† |
| Investing activities | ||||
| Additions to properties | (144)† | (148)† | (176) | (188)† |
| Issuance of notes receivable | — | — | — | 0† |
| Purchase of marketable securities | 0† | (2)† | (72) | (49)† |
| Sales of marketable securities | 14† | 14† | 84 | 64† |
| Purchases of available for sale securities | — | — | — | 0† |
| Sales of available for sale securities | — | — | — | 0† |
| Settlement of net investment hedges | (21)† | (34)† | 0 | 0† |
| Other | (5)† | 0† | 12 | 12† |
| Net cash provided by (used in) investing activities | (156)† | (170)† | (152) | (161)† |
| Financing activities | ||||
| Net issuances (reductions) of notes payable | (253)† | 199† | 474 | — |
| Issuances of long-term debt | 0† | — | — | 0† |
| Reductions of long-term debt | 0† | (1)† | (631) | (1)† |
| Net issuances of common stock | 14† | 46† | 42 | 23† |
| Common stock repurchases | — | — | — | 0† |
| Cash dividends | (203)† | (198)† | (197) | (196)† |
| Other | (13)† | (14)† | (1) | (4)† |
| Net cash provided by (used in) financing activities | (455)† | 32† | (313) | (190)† |
| Effect of exchange rate changes on cash and cash equivalents | (6)† | (7)† | (15) | 9† |
| Increase (decrease) in cash and cash equivalents | (114)† | 24† | (364) | 125† |
| Cash and cash equivalents at beginning of period | 354 | 330 | 694 | 569 |
| Cash and cash equivalents at end of period | 240 | 354 | 330 | 694 |
| Supplemental cash flow disclosures of non-cash investing activities | ||||
| Additions to properties included in accounts payable | (20)† | (17)† | 116 | 48† |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.